Literature DB >> 8516402

Bedside polysomnography as an adjunct in the management of infants with Robin sequence.

J T Gilhooly1, J D Smith, L L Howell, B L Deschaine, S L Richey.   

Abstract

Objective indications for tongue-lip adhesion in infants with Robin sequence have been lacking because of the difficulty in assessing the clinical significance of airway obstruction. In 1988, we began to use 20-hour, four-channel polysomnography to assist us in the management of infants with Robin sequence. The four channels included electrocardiogram, respiratory motion, airflow, and oxygen saturation. Infants demonstrating significant episodes of airway obstruction during sleep were recommended for tongue-lip adhesion. Fifteen infants with Robin sequence were evaluated during a 3-year period. Two babies were having severe, clinically obvious events on admission and underwent tongue-lip adhesion without polysomnography. Polysomnography was done on the other 13 infants. No significant events were seen in 7 infants, and they were discharged after a mean hospitalization of 8 days. Six studies documented significant airway obstruction, and tongue-lip adhesion was recommended. Follow-up polysomnography performed after successful tongue-lip adhesion failed to show any significant events, and the infants only required hospitalization for a mean of 12 days. We conclude that polysomnography is a useful adjunct in the management of infants with Robin sequence, providing objective indications for surgical intervention and shortening hospitalization.

Entities:  

Mesh:

Year:  1993        PMID: 8516402     DOI: 10.1097/00006534-199307000-00003

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  8 in total

1.  Longitudinal Sleep Outcomes in Neonates With Pierre Robin Sequence Treated Conservatively.

Authors:  Zarmina Ehsan; Christopher Kurian; K Nicole Weaver; Brian S Pan; Guixia Huang; Md M Hossain; Narong Simakajornboon
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

2.  Late presentation of upper airway obstruction in Pierre Robin sequence.

Authors:  A C Wilson; D J Moore; M H Moore; A J Martin; R E Staugas; J D Kennedy
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

Review 3.  Robin sequence: from diagnosis to development of an effective management plan.

Authors:  Kelly N Evans; Kathleen C Sie; Richard A Hopper; Robin P Glass; Anne V Hing; Michael L Cunningham
Journal:  Pediatrics       Date:  2011-04-04       Impact factor: 7.124

4.  Polysomnography-guided mandibular distraction osteogenesis in Pierre Robin sequence patients.

Authors:  Rashi Kochhar; Vikash Modi; Neranjan de Silva; Seyni Gueye-Ndiaye; Jay M Neugarten; Mary J Ward; Linda M Gerber; Anjile An; Elizabeth Mauer; Haviva Veler
Journal:  J Clin Sleep Med       Date:  2022-07-01       Impact factor: 4.324

5.  A pragmatic approach to infants with Robin sequence: a retrospective cohort study and presence of a treatment algorithm.

Authors:  Emma C Paes; Daan P F van Nunen; Lucienne Speleman; Marvick S M Muradin; Bram Smarius; Moshe Kon; Aebele B Mink van der Molen; Aebele B Mink van der Molen; Titia L E M Niers; Esther S Veldhoen; Corstiaan C Breugem
Journal:  Clin Oral Investig       Date:  2015-02-15       Impact factor: 3.573

6.  Management and outcomes of obstructive sleep apnea in children with Robin sequence, a cross-sectional study.

Authors:  Manouk J S van Lieshout; Koen F M Joosten; Maarten J Koudstaal; Marc P van der Schroeff; Karolijn Dulfer; Irene M J Mathijssen; Eppo B Wolvius
Journal:  Clin Oral Investig       Date:  2016-11-26       Impact factor: 3.573

7.  Polysomnographic findings in infants with Pierre Robin sequence.

Authors:  Abdullah Khayat; Saadoun Bin-Hassan; Suhail Al-Saleh
Journal:  Ann Thorac Med       Date:  2017 Jan-Mar       Impact factor: 2.219

8.  Birth prevalence and initial treatment of Robin sequence in Germany: a prospective epidemiologic study.

Authors:  Scarlet Vatlach; Christoph Maas; Christian F Poets
Journal:  Orphanet J Rare Dis       Date:  2014-01-17       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.